• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Recognized Consensus Standards

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | Registration & Listing | Adverse Events | Recalls | PMA | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

New Search Back To Search Results
Recognition List Number: 029 Publication Date: 08/20/2012 

Part B: SUPPLEMENTARY INFORMATION

Recognition Number 7-148: CLSI M28-A2, Procedures for the Recovery and Identification of Parasites from the Intestinal Tract; Approved Guideline - Second Edition. (InVitro Diagnostics)

Date of Standard: 2005. 
Address of Standards Organization:
  Clinical Laboratory Standards Institute (CLSI)
  950 West Valley Road
  Suite 2500
  Wayne, PA 19087
 
CDRH Office and Division Associated with Recognized Standards:
OFFICE OF IN VITRO DIAGNOSTICS AND RADIOLOGICAL HEALTH (OIR)
Devices Affected:
IVDs
Processes Affected:
510(K), IDE, PDP
Type of Standard:
 Horizontal, National
Extent of Recognition:
Complete standard
Related CFR Citations and Product Codes:
Regulation
Number
Device Name Device
Class
Product
Code
§866.3220 Antigen, Id, Ha, Cep, Entamoeba Histolytica & Rel. Spp. Class 2 KHW
§866.3220 Antigen, Latex Agglutination, Entamoeba Histolytica & Rel. Spp. Class 2 GMO
§866.3220 Cryptosporidium Spp. Class 2 MHJ
§866.3220 Giardia Spp. Class 2 MHI
§866.3220 Indirect Fluorescent Antibody Test, Entamoeba Histolytica & Rel Sp Class 2 GWD
 
Relevant Guidance:
There is no relevant guidance developed at this time.
FDA Technical Contact:
  Raquel Peat
  FDA/CDRH/OIVD
  10903 New Hampshire Avenue Building 66, Room 5561
  Silver Spring MD 20993
  301/796-6218
  Email: raquel.peat@fda.hhs.gov
-
-